Chronic Leukemia — Trials

Chronic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

1,705 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 207
Ph III recruiting: 22
Growth YoY: −13.3%
Industry share: 28%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 32.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (302)

clinicaltrialsPublishedShowing 301–350 of 358 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00230282	Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia	completed	Phase 2	25	Steven E. CoutreOTHER	1	Oct 6, 2014	clinicaltrials
NCT01557777	Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)	completed	Phase 2	17	AbbVie (prior sponsor, Abbott)INDUSTRY	5	Jul 4, 2014	clinicaltrials